116 related articles for article (PubMed ID: 35262522)
1. The Role of Human U Three Protein 14a as a Predictor for Hepatocellular Carcinoma Recurrence After Microwave Ablation.
Abdelkhalek Elhefni MM; Abd El Moety AA; Baddour NM; El Sayed Salem P
Appl Immunohistochem Mol Morphol; 2022 Mar; 30(3):171-177. PubMed ID: 35262522
[TBL] [Abstract][Full Text] [Related]
2. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
3. [Expression of hUTP14a in non-small cell lung cancer].
Zhang CF; Liu Y; Lu M; DU XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):145-150. PubMed ID: 30773559
[TBL] [Abstract][Full Text] [Related]
4. Human U3 protein 14a plays an anti-apoptotic role in cancer cells.
Ma T; Lu C; Guo Y; Zhang C; Du X
Biol Chem; 2017 Oct; 398(11):1247-1257. PubMed ID: 28672776
[TBL] [Abstract][Full Text] [Related]
5. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided percutaneous microwave ablation vs. surgical resection for thoracoabdominal wall implants from hepatocellular carcinoma: intermediate-term results.
An C; Hu ZL; Liang P; Cheng ZG; Han ZY; Yu J; Liu FY
Int J Hyperthermia; 2018 Nov; 34(7):1067-1076. PubMed ID: 29161924
[TBL] [Abstract][Full Text] [Related]
7. A small ribosomal subunit (SSU) processome component, the human U3 protein 14A (hUTP14A) binds p53 and promotes p53 degradation.
Hu L; Wang J; Liu Y; Zhang Y; Zhang L; Kong R; Zheng Z; Du X; Ke Y
J Biol Chem; 2011 Jan; 286(4):3119-28. PubMed ID: 21078665
[TBL] [Abstract][Full Text] [Related]
8. Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.
Wang WQ; Lv X; Li J; Li J; Wang JL; Yuan T; Liu JJ; Zhu RH; Huang ZY; Zhang EL
Eur J Surg Oncol; 2023 May; 49(5):1001-1008. PubMed ID: 36585301
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
10. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma.
Medhat E; Abdel Aziz A; Nabeel M; Elbaz T; Zakaria Z; Shousha H; Amer A; Fouad Fathalah W; Maher R; Musa S
J Dig Dis; 2015 Aug; 16(8):456-63. PubMed ID: 25958973
[TBL] [Abstract][Full Text] [Related]
11. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
[TBL] [Abstract][Full Text] [Related]
12. Different power modes of microwave ablation for hepatocellular carcinoma: Evaluation of recurrence rate and factors related to recurrence.
Dong T; Nie F; Liu T; Wang L; Yang D; Yan X
Asian J Surg; 2023 Sep; 46(9):3520-3528. PubMed ID: 37002048
[TBL] [Abstract][Full Text] [Related]
13. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.
Sun AX; Cheng ZL; Wu PP; Sheng YH; Qu XJ; Lu W; Zhao CG; Qian GJ
World J Gastroenterol; 2015 Mar; 21(10):2997-3004. PubMed ID: 25780298
[TBL] [Abstract][Full Text] [Related]
15. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe: A pilot clinical study.
Peng Y; Cui D; Li W; Ding M; Shi Y; Wang T; Shi D; Chi J; Li P; Zhai B
J Cancer Res Ther; 2021 Jul; 17(3):764-770. PubMed ID: 34269311
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis.
Soliman AF; Abouelkhair MM; Hasab Allah MS; El-Kady NM; Ezzat WM; Gabr HA; Elsayed EH; Saleh AI; Kamel A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):295-301. PubMed ID: 30678453
[TBL] [Abstract][Full Text] [Related]
18. Effect of microwave ablation on platelet and coagulation function in patients with BCLC-A hepatocellular carcinoma.
Zhao W; Li H; Li W; Guo J; Cai L; Duan Y; Hou X; Diao Z; Shao X; Du H; Li W; Li C
J Cancer Res Ther; 2021 Nov; 17(5):1275-1280. PubMed ID: 34850778
[TBL] [Abstract][Full Text] [Related]
19. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
20. Combined Transarterial Chemoembolization with Microwave Ablation
El-Agawy W; El-Ganainy SA; Gad MAA; Abd-Elsalam S; Mostafa WAA; El-Shewi ME
Curr Cancer Drug Targets; 2022; 22(1):77-85. PubMed ID: 35078397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
